Research.Patient.info
Cutaneous Squamous Cell Carcinoma (CSCC) research hub
2 indexed studies · 1 currently recruiting
- recruiting
Follow-up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment.
This study looks at how skin cancer called cutaneous squamous cell carcinoma (CSCC) is treated in France. It focuses on patients who need medicines that work throughout the body, to see what treatments are used, how well they work, and if they have side effects, over a long time.
France - ongoing, recruitingTherapeutic exploratory (Phase II)
A Multicenter, Open-label, Phase 2 study of Intratumoral Vidutolimod (CMP-001) in Combination with Intravenous Cemiplimab in Subjects with Selected Types of Advanced or Metastatic Cancer
This study is testing a new combination of treatments for some advanced cancers. It involves two drugs, Vidutolimod and Cemiplimab, to see how well they shrink tumours. It's a Phase II study, meaning we're looking at how safe and effective this new approach might be.
France